Halozyme Therapeutics (NasdaqGS:HALO) FY Conference December 02, 2025 01:20 PM ET Company ParticipantsHelen Torley - President and CEOConference Call ParticipantsMichael DiFiore - Senior Biotech AnalystMichael DiFioreOkay, let's get started. Welcome, everybody. Welcome to our conference in Miami. I have the pleasure of having Dr. Helen Torley, CEO of Halozyme Therapeutics. Helen, welcome. Thanks so much for making time for us. Before we delve into Q&A, I'd love to get your overview of the business and maybe ...